ici 204,219 has been researched along with Cystic Fibrosis of Pancreas in 2 studies
zafirlukast: a leukotriene D4 receptor antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conway, SP | 1 |
| Etherington, C | 1 |
| Peckham, DG | 1 |
| Whitehead, A | 1 |
| Santais, MC | 1 |
| Callens, E | 1 |
| Djebbar, R | 1 |
| Ruff, F | 1 |
1 review available for ici 204,219 and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
[Potential importance of antileukotrienes in the treatment of asthma and other inflammatory diseases: apropos of a new pharmacological class].
Topics: Acetophenones; Adult; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthr | 1998 |
1 trial available for ici 204,219 and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
A pilot study of zafirlukast as an anti-inflammatory agent in the treatment of adults with cystic fibrosis.
Topics: Adult; Anti-Inflammatory Agents; Cystic Fibrosis; Female; Humans; Indoles; Leukotriene Antagonists; | 2003 |